title: Subcutaneous Taenia crassiceps infection in a patient with non-Hodgkin's lymphoma.
abstract: Infections with larvae of Taenia crassiceps are rare in humans and have mostly affected patients with acquired immunodeficiency syndrome. We report the first case of a patient with malignancy (non-Hodgkin's lymphoma) and infection of the subcutis and muscles of the hand and forearm. Surgery and antiparasitic chemotherapy led to a complete cure.
authors.affiliation: Medical and Surgery Department, General Hospital Trostberg, Trostberg, Germany.
authors.forename: Katharina
authors.initials: K
authors.lastname: Heldwein
authors.forename: Hans-Gernot
authors.initials: HG
authors.lastname: Biedermann
authors.forename: Wolf-Dieter
authors.initials: WD
authors.lastname: Hamperl
authors.forename: Gisela
authors.initials: G
authors.lastname: Bretzel
authors.forename: Thomas
authors.initials: T
authors.lastname: Löscher
authors.forename: Davide
authors.initials: D
authors.lastname: Laregina
authors.forename: Matthias
authors.initials: M
authors.lastname: Frosch
authors.forename: Dietrich W
authors.initials: DW
authors.lastname: Büttner
authors.forename: Dennis
authors.initials: D
authors.lastname: Tappe
mesh_terms: D000369:Aged, 80 and over; D015766:Albendazole / Q000008:administration & dosage; D000818:Animals; D003520:Cyclophosphamide / Q000276:immunology; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007814:Larva / Q000472:pathogenicity / Q000648:ultrastructure; D008228:Lymphoma, Non-Hodgkin / Q000150:complications*; D011223:Praziquantel / Q000008:administration & dosage; D040521:Subcutaneous Tissue / Q000469:parasitology / Q000473:pathology / Q000601:surgery; D013621:Taenia / Q000302:isolation & purification* / Q000472:pathogenicity / Q000648:ultrastructure; D013622:Taeniasis / Q000150:complications* / Q000628:therapy*; D001084:Vidarabine Phosphate / Q000031:analogs & derivatives / Q000276:immunology
chemical_list: D001084:Vidarabine Phosphate; C042382:fludarabine phosphate; D011223:Praziquantel; D003520:Cyclophosphamide; D015766:Albendazole